Dr. Geilinger is Member of the Advisory Board of BioMedInvest II LP.

Dr. Geilinger is head of private equity at HBM Partners AG, Zug, a leading venture capital advisory firm.

He has over 20 years of private equity and venture capital experience at Innoventure, Credit Suisse, Apax and Vontobel.

Dr. Geilinger has extensive experience as a board member in small and medium-sized private life sciences companies. Currently he is a board member of HBM Partners, Westmed, Reha Technology and Medimpulse/Biocontrol.

He is a former board member of EVCA and former president of the Swiss Private Equity & Corporate Finance Association.

Dr. Geilinger studied natural sciences and industrial engineering at Swiss Federal Institute of Technology (ETH), Zurich, and completed his studies with a PhD.